Preview: Fennec Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Fennec Pharmaceuticals (NASDAQ:FENC) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.11. The company's past performance shows a pattern of EPS misses, with the last quarter missing by $0.05. The share price increased by 0.25% the next day. The company's shares were trading at $6.96 as of November 2, with a 52-week decrease of 18.54%.
November 03, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Fennec Pharmaceuticals is expected to report an EPS of $-0.11. The company's stock has been on a downward trend, with a 52-week decrease of 18.54%.
The company's stock has been on a downward trend, and it has a history of missing EPS estimates. This could potentially lead to a further decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100